Tilray Brands is trading at $3.04, down 5.14%, with broad market weakness the clearest context for the October 16 decline.
- No fresh company-specific announcement explaining the decline surfaced in the search.
- Reuters reported technology-led selling amid higher-rate concerns and debt worries around AI infrastructure, with major U.S. indexes lower during Friday trading.
- Earlier fiscal Q1 results showed cannabis revenue fell to $56.1 million from $64.5 million; this is background, not a confirmed cause.